1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow MGB Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerance and Effectiveness of C14 on HPV Infection The monoterpenoid zinc tetra-ascorbo-camphorate ("C14"), Distilled water group - HPV-induced Cancers, HPV Infections | Phase 1 / Phase 2 | Not yet recruiting | MGB Pharma | 66 | 2024-11-15 | 2024-11-04 |
Papillomavirus Infections (1) · Uterine Cervical Neoplasms (1)
Carbon-14 (1)
Democratic Republic of the Congo (1)